In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.

This Primer by Wilson and colleagues summarizes the epidemiology, pathophysiology, diagnosis and treatment of neurological and psychiatric manifestations of COVID-19.

Woolf argues that illness is ‘the great confessional’ which is never talked about in literature.

Background mTOR activation is associated with chronic inflammation in ME/CFS. Previous studies have shown that sustained mTOR activation may cause chronic muscle fatigue by inhibiting ATG13-mediated a...

In this session, we will share updates on how the Long COVID Treatment Trial-Tirzepatide (LoCITT-T) is progressing and discuss why continued engagement from all study participants is important for gen...

Mounting evidence points to a link between new-onset allergies and Long COVID, with mast cell activation syndrome as a potential culprit.

There’s still a ways to go before doctors and scientists fully understand pediatric long COVID, but three upcoming clinical trials are on the horizon.

Geoff’s Narration The GIST Muscles on a Chip Whoa, another muscle study. We recently reported on a proteomic study suggesting that muscle repair problems contribute to post-exertional malaise in ME/CF...

When acute SARS-CoV-2 infections cause symptoms that persist longer than 3 months, this condition is termed long COVID. Symptoms experienced by patients often include myalgia, fatigue, brain fog, cogn...

Long COVID patients can experience severe energy crashes after physical exertion. New research provides clear evidence that there's a biological basis for the symptoms.

INTERVIEW. Le Dr Pascale Favre, autrice d’une note de la Fondapol, constate que les pays qui ont légalisé cette pratique ont élargi son champ d’application, provoquant l’explosion des demandes.

YouTube video by Nathan Fernandez

Helen Lunt Davies said she had struggled with heart palpitations, migraines and fatigue.

Explaining the one important lesson that he wanted you to learn.

The Long COVID Treatment Trial-Tirzepatide (LoCITT-T) is investigating the efficacy of repurposing this drug to treat Long COVID.